GAFFX | MEGRX | GAFFX / MEGRX | |
Total Expense Ratio | 0.30 | 1.08 | 28% |
Annual Report Gross Expense Ratio | 0.30 | 1.09 | 28% |
Fund Existence | 9 years | 22 years | - |
Gain YTD | 13.509 | 9.865 | 137% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 328B | 47.2B | 695% |
Annual Yield % from dividends | 0.61 | 0.00 | - |
Returns for 1 year | 18.19 | 5.84 | 312% |
Returns for 3 years | 59.69 | 48.98 | 122% |
Returns for 5 years | 50.79 | 42.88 | 118% |
Returns for 10 years | N/A | 159.44 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MDY | 587.77 | 5.28 | +0.91% |
SPDR® S&P MIDCAP 400 ETF Trust | |||
GARP | 62.17 | 0.43 | +0.70% |
iShares MSCI USA Quality GARP ETF | |||
UMAR | 38.17 | 0.13 | +0.33% |
Innovator U.S. Equity Ultra BffrETF™-Mar | |||
GNOM | 9.04 | 0.02 | +0.23% |
Global X Genomics & Biotechnology ETF | |||
AGQ | 52.74 | -2.77 | -4.99% |
ProShares Ultra Silver |